Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1475 of 1674 entries
View as:

Trial Evaluating the Efficacy of a Chlorhexidine-Impregnated Sponge (BIOPATCH®) to Reduce Catheter-Related Bloodstream Infections in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00550693 Org: User:
Start: 04/30/04 End: 03/31/05 Due: 03/31/06

Small Extracellular Vesicles and Insulin Action

Phase: N/A Priority: Normal
NCT ID: NCT05933707 Org: User:
Start: 06/08/23 End: 12/31/28 Due: 12/31/29

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00545519 Org: User:
Start: 10/31/06 End: 03/31/08 Due: 03/31/09

Systemic Absorption of Lidocaine After Hematoma Block

Phase: N/A Priority: Normal
NCT ID: NCT04359017 Org: User:
Start: 11/01/20 End: 12/01/23 Due: 12/01/24

Positron Emission Tomography in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00121212 Org: User:
Start: 07/31/03 End: 10/31/15 Due: 10/31/16

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

Phase: N/A Priority: Normal
NCT ID: NCT04968964 Org: User:
Start: 03/07/22 End: 09/30/29 Due: 09/30/30

Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus

Phase: N/A Priority: Normal
NCT ID: NCT00133107 Org: User:
Start: 01/31/05 End: 11/30/05 Due: 11/30/06

Stigma and a Shared Decision Aid

Phase: N/A Priority: Normal
NCT ID: NCT05352412 Org: User:
Start: 04/07/22 End: 03/31/24 Due: 03/31/25

Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02299141 Org: User:
Start: 05/07/15 End: 04/23/25 Due: 04/23/26

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT06529822 Org: User:
Start: 03/20/25 End: 09/30/33 Due: 09/30/34

Acceptability and Performance of HIV Self-Testing in a Youth Population in Nigeria

Phase: N/A Priority: Normal
NCT ID: NCT03874663 Org: User:
Start: 11/20/18 End: 05/08/20 Due: 05/08/21

Suubi4StrongerFamilies

Phase: N/A Priority: Normal
NCT ID: NCT05368714 Org: User:
Start: 06/14/22 End: 04/01/27 Due: 04/01/28

Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention

Phase: N/A Priority: Normal
NCT ID: NCT06562439 Org: User:
Start: 01/01/25 End: 07/31/28 Due: 07/31/29

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT05829460 Org: User:
Start: 03/12/25 End: 04/30/32 Due: 04/30/33

Neural Facilitation of Movements in People With SCI

Phase: N/A Priority: Normal
NCT ID: NCT05354206 Org: User:
Start: 06/23/22 End: 03/06/23 Due: 03/06/24

Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

Phase: N/A Priority: Normal
NCT ID: NCT04893915 Org: User:
Start: 06/30/22 End: 12/31/24 Due: 12/31/25

M-Suubi: a Multi-Level Integrated Intervention to Reduce the Impact of HIV Stigma

Phase: N/A Priority: Normal
NCT ID: NCT05307250 Org: User:
Start: 03/15/22 End: 07/31/26 Due: 07/31/27

Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04887935 Org: User:
Start: 06/04/24 End: 08/31/26 Due: 08/31/27

Starting a Testosterone and Exercise Program After Hip Injury

Phase: N/A Priority: Normal
NCT ID: NCT02938923 Org: User:
Start: 03/05/19 End: 11/06/23 Due: 11/06/24

A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT05903131 Org: User:
Start: 10/24/24 End: 10/31/29 Due: 10/31/30

Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition

Phase: N/A Priority: Normal
NCT ID: NCT06869850 Org: User:
Start: 07/01/25 End: 11/01/27 Due: 11/01/28

Parathyroid Tumor Clonal Status

Phase: N/A Priority: Normal
NCT ID: NCT05997810 Org: User:
Start: 04/11/23 End: 01/31/27 Due: 01/31/28

Eye Patch Therapy for Central Serous Retinopathy (CSR)

Phase: N/A Priority: Normal
NCT ID: NCT02036632 Org: User:
Start: 11/30/12 End: 01/31/15 Due: 01/31/16

Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)

Phase: N/A Priority: Normal
NCT ID: NCT03380351 Org: User:
Start: 08/26/19 End: 03/30/24 Due: 03/30/25

Actinic Keratosis Study

Phase: N/A Priority: Normal
NCT ID: NCT02019355 Org: User:
Start: 10/31/13 End: 03/31/15 Due: 03/31/16